Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes

Sponsor
University of Colorado, Denver (Other)
Overall Status
Completed
CT.gov ID
NCT02473926
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
55
1
2
43.9
1.3

Study Details

Study Description

Brief Summary

This study plans to learn more about physical activity and physical function in sedentary older adults with type 2 diabetes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity
  • Behavioral: Questionnaires
N/A

Detailed Description

The purpose of this study is to conduct a randomized controlled trial with 1:1 patient-level randomization to an evidence-based physical activity program intervention versus usual care in sedentary older adults with type 2 diabetes in two primary care clinic sites.

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes
Actual Study Start Date :
Dec 1, 2015
Actual Primary Completion Date :
Jun 1, 2019
Actual Study Completion Date :
Jul 29, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical Activity Program Intervention

The intervention seeks to increase physical activity and improve strength by addressing individual , behavioral, and social/environmental factors. Health promotion clinic staff will deliver counseling by phone on a bi-weekly basis - a clinic physician assistant will coordinate with the counselor during in-person clinic visits, teach participants to perform strengthening exercise, and assess for safety concerns associated with type 2 diabetes. In addition to behavioral counseling targeting social cognitive theory constructs, counselors will assist participants in the intervention group to set specific goals for physical activity in a paper log and on an electronic FitBit activity tracking device.Health promotion clinic staff will encourage participants to advance goals towards meeting U.S. physical activity guidelines of 150 minutes/week of moderate intensity activity and 2-3 days/week of strength activities.

Behavioral: Physical Activity
Physical Activity Program Intervention

Other: Usual Care Group

Participants in the usual care arm will receive three mailings (Intervention Questionnaires) during the intervention phase. Health promotion clinic staff will mail materials from the Center for Disease Control and Prevention website that address general health aging topics.

Behavioral: Questionnaires
Participants in the usual care arm will receive three mailings during the intervention phase.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline in Objective Physical Activity at 4 months [Week 1; Week 14]

    ActiGraph accelerometer measures physical activity objectively as minutes/week of moderate intensity and vigorous intensity physical activity, respectively.

Secondary Outcome Measures

  1. Change from Baseline in Physical Function at 4 months [Week 1; week 14]

    Measured via 400-meter rapid gait speed test

  2. Change from Baseline in Physical Function at 4 months [Week 0, Week 14]

    Measured via the Short Physical Performance Battery (SPPB), which evaluates balance, usual walking speed, and repeated chair rise.

  3. Change from Baseline in Grip Strength at 4 months [Week 2; Week 15]

    Hand grip strength as measured by dynamometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of type 2 diabetes

  • Sedentary individual, performing <20 minutes of physical activity on <3 days/week

Exclusion Criteria:
  • Dementia (Folstein Mini-Mental Status Exam <24) or clinical diagnosis

  • Excessive fall risk: Can not hold semi-tandem stance for >10 seconds

  • Type 2 diabetes-related safety concerns: Prior diabetic foot ulcer, Charcot foot, asymptomatic hypoglycemia

  • Severely uncontrolled hypertension (BP >180/100)

  • Excessive hearing or visual impairment for counseling

  • Limited life expectancy: Active treatment for malignancy

  • Performs regular physical activity >20 minutes on >3 days/week

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Colorado Denver | Anschutz Medical Campus Aurora Colorado United States 80045

Sponsors and Collaborators

  • University of Colorado, Denver
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Amy Huebschmann, MD, University of Colorado, Denver

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT02473926
Other Study ID Numbers:
  • 15-1080
  • K23HL118133
First Posted:
Jun 17, 2015
Last Update Posted:
Sep 24, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by University of Colorado, Denver
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 24, 2021